Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models

Physiological Genomics

Volumn 44, Issue 8, 2012, Pages 443-454

  Lu, Bo ^a   Yu, Hongjuan ^a   Zwartbol, Maarten ^a   Ruifrok, Willem P ^a   van Gilst, Wiek H ^a   de Boer, Rudolf A ^a   Silljé, Herman H W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiomyocyte; Fetal gene program; Gene array; Gene expression

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; FHL1 PROTEIN; ISOPRENALINE; PHENYLEPHRINE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID OXIDATION; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; WOUND;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION; HEART FAILURE; MALE; MYOCYTES, CARDIAC; RATS; RENIN;

ANIMALIA; RATTUS;

EID: 84859759432     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00148.2011     Document Type: Article

References (32)

1. Asakura M, Kitakaze M. Global gene expression profiling in the failing myocardium. Circ J 73: 1568-1576, 2009.
2. Brass EP, Peters MA, Hinchcliff KW, He YD, Ulrich RG. Temporal pattern of skeletal muscle gene expression following endurance exercise in Alaskan sled dogs. J Appl Physiol 107: 605-612, 2009.
3. Cheng TH, Chen JJ, Shih NL, Lin JW, Liu JC, Chen YL, Chen CH, Chen JJ. Mechanical stretch induces endothelial nitric oxide synthase gene expression in neonatal rat cardiomyocytes. Clin Exp Pharmacol Physiol 36: 559-566, 2009.
4. Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105: 301-313, 2010.
5. Cullingford TE, Markou T, Fuller SJ, Giraldo A, Pikkarainen S, Zoumpoulidou G, Alsafi A, Ekere C, Kemp TJ, Dennis JL, Game L, Sugden PH, Clerk A. Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes. Genome Biol 9: R32, 2008.
6. de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, van Veldhuisen DJ. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 43: 60-68, 2011.
7. de Boer RA, Pokharel S, Flesch M, van Kampen DA, Suurmeijer AJ, Boomsma F, van Gilst WH, van Veldhuisen DJ, Pinto YM. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J Mol Med 82: 678-687, 2004.
8. de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 11: 811-817, 2009.
9. Feng Y, Vom Hagen F, Wang Y, Beck S, Schreiter K, Pfister F, Hoffmann S, Wagner P, Seeliger M, Molema G, Deutsch U, Hammes HP. The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy. Thromb Haemost 102: 120-130, 2009.
10. Francois H, Athirakul K, Howell D, Dash R, Mao L, Kim HS, Rockman HA, Fitzgerald GA, Koller BH, Coffman TM. Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab 2: 201-207, 2005.
11. Frank D, Kuhn C, Brors B, Hanselmann C, Ludde M, Katus HA, Frey N. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 51: 309-318, 2008.
12. Gao N, Asamitsu K, Hibi Y, Ueno T, Okamoto T. AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. J Biol Chem 283: 7834-7843, 2008.
13. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600, 2006.
14. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 358: 1370-1380, 2008.
15. Iniguez MA, Cacheiro-Llaguno C, Cuesta N, Diaz-Munoz MD, Fresno M. Prostanoid function and cardiovascular disease. Arch Physiol Biochem 114: 201-209, 2008.
16. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. Alpha-and betaadrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. J Biol Chem 265: 13809-13817, 1990.
17. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 21: 661-672, 2001.
18. Lee MA, Bohm M, Paul M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(m-REN2)27. Am J Physiol Endocrinol Metab 270: E919-E929, 1996.
19. Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res 90: 202-209, 2011.
20. Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, van Veldhuisen DJ, Schoemaker RG, van Gilst WH. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur J Heart Fail 10: 22-29, 2008.
21. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
22. Lu B, Mahmud H, Maass AH, Yu B, van Gilst WH, de Boer RA, Sillje HH. The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro. PLoS One 5: e12963, 2010.
23. Lu B, Tigchelaar W, Ruifrok WP, van Gilst WH, de Boer RA, Sillje HH. DHRS7c, a novel cardiomyocyte-expressed gene that is downregulated by adrenergic stimulation and in heart failure. Eur J Heart Fail 14: 5-13, 2012.
24. Matsui T, Hayashi-Kisumi F, Kinoshita Y, Katahira S, Morita K, Miyachi Y, Ono Y, Imai T, Tanigawa Y, Komiya T, Tsukita S. Identification of novel keratinocyte-secreted peptides dermokine-alpha/-beta and a new stratified epithelium-secreted protein gene complex on human chromosome 19q13.1. Genomics 84: 384-397, 2004.
25. Nakayama T. Genetic polymorphisms of prostacyclin synthase gene and cardiovascular disease. Int Angiol 29, Suppl: 33-42, 2010.
26. Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann NY Acad Sci 1123: 30-40, 2008.
27. Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HH. Glucagon-like peptide 1 prevents reactive oxygen speciesinduced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol 30: 1407-1414, 2010.
28. Osadchii OE. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev 12: 66-86, 2007.
29. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12: 331-343, 2007.
30. Ruifrok WP, Qian C, Sillje HH, van Goor H, van Veldhuisen DJ, van Gilst WH, de Boer RA. Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin. J Mol Med 89: 377-387, 2011.
31. Sastri M, Barraclough DM, Carmichael PT, Taylor SS. A-kinaseinteracting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci USA 102: 349-354, 2005.
32. Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28: 2018-2027, 2007.